博瑞医药
(688166)
| 流通市值：130.63亿 | | | 总市值：130.63亿 |
| 流通股本：4.22亿 | | | 总股本：4.22亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 505,357,865.57 | 954,158,968.11 | 984,473,291.77 | 998,045,685.92 |
| 应收票据及应收账款 | 369,536,455.4 | 319,512,697.57 | 253,930,122.59 | 285,343,836.71 |
| 其中：应收票据 | 0 | 1,016,596.65 | 3,124,400 | 2,365,608.4 |
| 应收账款 | 369,536,455.4 | 318,496,100.92 | 250,805,722.59 | 282,978,228.31 |
| 应收款项融资 | 2,253,603.74 | 19,384,701.6 | 8,412,412 | 23,531,508.68 |
| 预付款项 | 107,954,668.17 | 46,917,582.05 | 70,403,163.32 | 52,449,158.94 |
| 其他应收款合计 | 3,032,209.5 | 2,890,743.76 | 16,429,065.1 | 19,914,098.86 |
| 其中:应收利息 | 0 | 0 | - | 0 |
| 应收股利 | 0 | 0 | - | 0 |
| 存货 | 339,742,470.71 | 330,269,983.6 | 331,860,003.39 | 344,627,860.71 |
| 其他流动资产 | 54,640,056.19 | 64,818,111.9 | 59,905,013.66 | 65,209,123.12 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,382,517,329.28 | 1,737,952,788.59 | 1,776,422,797.85 | 1,839,738,327.73 |
| 非流动资产: | | | | |
| 长期股权投资 | 39,325,778.89 | 41,588,602.44 | 40,075,155.38 | 43,490,102.12 |
| 其他权益工具投资 | 85,453,039.67 | 85,474,967.03 | 108,385,367.37 | 110,699,517.63 |
| 其他非流动金融资产 | 58,945,678.24 | 109,343,668.85 | 94,760,456.16 | 79,983,320.06 |
| 投资性房地产 | 60,286,957.93 | 61,007,580.61 | 61,728,203.29 | 62,454,445.65 |
| 固定资产 | 1,075,681,761.85 | 842,255,688.67 | 825,910,100.48 | 718,121,508.52 |
| 在建工程 | 1,621,450,042.69 | 1,779,599,927.9 | 1,765,715,052.83 | 1,736,234,888.16 |
| 使用权资产 | 23,513,017.43 | 26,993,922.36 | 30,576,208.74 | 34,158,495.11 |
| 无形资产 | 90,827,095.4 | 92,312,628.87 | 92,359,278.78 | 93,664,771.45 |
| 开发支出 | 9,258,962.26 | - | - | 0 |
| 商誉 | 7,500,000 | 7,500,000 | 7,500,000 | 7,500,000 |
| 长期待摊费用 | 28,604,665.65 | 38,326,305.07 | 28,716,898.87 | 30,184,563.96 |
| 递延所得税资产 | 56,071,439.09 | 55,492,646.2 | 44,149,550.75 | 42,280,888.95 |
| 其他非流动资产 | 339,097,043.42 | 352,819,435.25 | 211,207,819.91 | 233,320,546.58 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,496,015,482.52 | 3,492,715,373.25 | 3,311,084,092.56 | 3,192,093,048.19 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,878,532,811.8 | 5,230,668,161.84 | 5,087,506,890.41 | 5,031,831,375.92 |
| 流动负债: | | | | |
| 短期借款 | 122,138,205.34 | 135,620,628.7 | 206,581,677.54 | 156,873,727.68 |
| 交易性金融负债 | 382,600 | 3,184,170.1 | 4,774,990 | 2,234,420 |
| 应付票据及应付账款 | 213,842,003.41 | 215,993,620.09 | 217,380,646.06 | 228,177,443.12 |
| 其中：应付票据 | 39,775,702.02 | 20,103,911 | 45,000,000 | 40,000,000 |
| 应付账款 | 174,066,301.39 | 195,889,709.09 | 172,380,646.06 | 188,177,443.12 |
| 合同负债 | 28,549,329.77 | 32,468,089.17 | 32,349,375.94 | 24,003,258.96 |
| 应付职工薪酬 | 14,637,196.78 | 14,402,534.99 | 37,883,177.95 | 49,126,635.8 |
| 应交税费 | 15,972,449.15 | 17,411,150.59 | 12,213,839.73 | 17,897,050.18 |
| 其他应付款合计 | 9,341,695.56 | 49,875,713.87 | 8,377,524.73 | 9,821,168.73 |
| 其中:应付利息 | 0 | 0 | - | 0 |
| 应付股利 | 0 | 40,521,898.78 | - | 0 |
| 一年内到期的非流动负债 | 463,613,234.3 | 527,574,129.86 | 462,109,410.72 | 414,031,035.6 |
| 其他流动负债 | 17,007,915.47 | 16,574,843.75 | 17,632,473.27 | 20,082,776.21 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 885,484,629.78 | 1,013,104,881.12 | 999,303,115.94 | 922,247,516.28 |
| 非流动负债: | | | | |
| 长期借款 | 1,104,249,061.43 | 1,268,314,033.31 | 1,105,726,453.02 | 1,184,658,415.12 |
| 应付债券 | 448,356,214.47 | 441,326,643.98 | 434,392,484.6 | 430,260,881.21 |
| 租赁负债 | 20,053,243.33 | 15,479,656.99 | 18,099,696.78 | 21,011,016.38 |
| 长期应付款 | 69,550,000 | 69,550,000 | 46,820,000 | 46,820,000 |
| 递延收益 | 8,500,000 | 8,750,000 | 9,000,000 | 9,250,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,650,708,519.23 | 1,803,420,334.28 | 1,614,038,634.4 | 1,692,000,312.71 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,536,193,149.01 | 2,816,525,215.4 | 2,613,341,750.34 | 2,614,247,828.99 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 422,466,561 | 422,466,561 | 422,466,561 | 422,466,533 |
| 其他权益工具 | 75,639,635.72 | 75,639,635.72 | 75,639,635.72 | 75,639,798.41 |
| 资本公积 | 949,381,893.93 | 1,055,483,106.28 | 1,057,133,106.28 | 1,057,132,047.12 |
| 减:库存股 | 10,009,948.64 | 10,009,948.64 | 2,944,041.21 | 0 |
| 其他综合收益 | -119,642,893.27 | -119,418,660.46 | -86,567,116.76 | -84,281,994.28 |
| 盈余公积 | 67,219,535.13 | 67,219,535.13 | 67,219,535.13 | 67,219,535.13 |
| 未分配利润 | 967,326,338.8 | 896,282,320.1 | 894,509,403.33 | 830,439,484.62 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,352,381,122.67 | 2,387,662,549.13 | 2,427,457,083.49 | 2,368,615,404 |
| 少数股东权益 | -10,041,459.88 | 26,480,397.31 | 46,708,056.58 | 48,968,142.93 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,342,339,662.79 | 2,414,142,946.44 | 2,474,165,140.07 | 2,417,583,546.93 |
| 负债和股东权益合计 | 4,878,532,811.8 | 5,230,668,161.84 | 5,087,506,890.41 | 5,031,831,375.92 |
| 公告日期 | 2024-10-30 | 2024-08-24 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |